Radiation Therapy for Malignancies in the Setting of HIV Disease

ONCOLOGY

Volumn 11, Issue 5, 1997, Pages 683-694

  Swift, Patrick S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; NONHODGKIN LYMPHOMA; REVIEW; UTERINE CERVIX TUMOR;

FEMALE; HIV INFECTIONS; HUMANS; LYMPHOMA, NON-HODGKIN; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 0031132603     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. HIV/AIDS Surveillance Report US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 1996.
2. Global Programme on AIDS Report. World Health Organization, 1995.
3. Katz MH, Hessol NA, Buchbinder SP, et al: Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 170:198-202, 1994.
4. Levine AM: AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 85:1382-1397, 1993.
5. Saah AJ, Hoover DR, He Y, et al: Factors influencing survival after AIDS: Report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 7:287-295, 1994.
6. Melbye M, Cote TR, Kessler L, et al: High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 343-636-639, 1994.
7. Errante D, Zagonel V, Vaccher E, et al: Hodgkin's disease in patients with HIV infection and in the general population. Comparison of clinicopathological features and survival. Ann Oncol 2:37-40, 1994.
8. Folks TM, Hart CE: The life cycle of human immunodeficiency virus type 1, in De Vita VT, Hellman S, Rosenberg SA, (eds): AIDS Etiology, Diagnosis, Treatment and Prevention 1997, pp 29-44. Philadelphia, Lippincott-Raven, 1997.
9. Levine AM,Tulpule A, Espina B, et al: Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer 78:517-526, 1996.
10. Sparano JA, Sarta C: Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy. Current Opin Oncol 8:392-399, 1996.
11. Madden BP, Backhouse L, McClosky D, et al: Total lymphoid irradiation as rescue therapy after heart transplantation. J Heart Lung Transplant 15.234-238, 1996.
12. Fultz PN, Schwiebert RS, Su L, et al: Effects of total lymphoid irradiation on SIV-infected macaques. AIDS Res Hum Retrovir 11:1517-1527, 1995.
13. McCune JM: Viral latency in HIV disease. Cell 82:183-188, 1995.
14. Valeric K, Laster WS, Kirkham JC, et al: Ionizing radiation activates nuclear factor kappa B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells. Biochemistry 34:15768-15776, 1995.
15. Xu Y, Conway B, Montaner JS, et al: Effect of low-dose gamma radiation of HIV replication in human peripheral blood mononuclear cells. Photochem Photobiol 64:238-241, 1996.
16. Carpenter CC, Fischl MA, Hammer SM, et al: Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. International AIDS Society-USA. JAMA 276:146-154, 1996.
17. Katzenstein DA, Hammer SM, Hughes MD, et al: The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 335:1091-1098, 1996.
18. Coombs RW: HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS. Clin Lab Med 14-301-311, 1994.
19. Phair JP: Estimating prognosis in HIV-1 infection (editorial). Ann Intern Med 118:742-744, 1993.
20. Klatt EC, Nichols L, Noguchi TT: Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome: 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1992-1993. Arch Pathol Lab Med 118:884-890, 1994.
21. Peterman TA, Jaffe HW, Beral V: Epidemiologic clues to the etiology of Kaposi's sarcoma (editorial). AIDS 7:605-611, 1993.
22. Tappero JW, Conant MA, Wolfe SF, et al: Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 28:371-395, 1993.
23. Meyer JL: Whole-lung irradiation for Kaposi's sarcoma. Am J Clin Oncol 16: 372-376, 1993.
24. Pantaleo G, Menzo S, Vaccarezza M, et al: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209-216, 1995.
25. Fischl MA, Stanley K, Collier AC, et al: Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease: The NIAID AIDS Clinical Trials Group. Ann Intern Med 122:24-32, 1995.
26. Lau RK, Hill A, Jenkins P, et al: Eight year prospective study of HIV infection in a cohort of homosexual men - clinical progression, immunological and virological markers. Int J Std AIDS 3:261-266, 1992.
27. Boudreaux AA, Smith LL, Cosby CD, et al: Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficacy and discomfort associated with infection. J Am Acad Dermatol 28:61-65, 1993.
28. Northfelt DW: Treatment of Kaposi's Sarcoma: Current guidelines and future perspectives. Drugs 48-569-582, 1994.
29. Bernstein ZP, Porter MM, Gould M, et al: Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 86:3287-3294, 1995.
30. McNamee D: Beta-hCG inhibits Kaposi's sarcoma. Lancet 345-1169, 1995.
31. Fife K, Bower M: Recent insights into the pathogenesis of Kaposi's Sarcoma. Br J Cancer 73:1317-1322, 1996.
32. Formenti SC, Chak L, Gill P, et al: Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's Sarcoma. Int J Radiat Biol 68:411-412, 1995.
33. Gao SJ, Kingsley L, Hoover DR, et al: Seroconversion to antibodies against Kaposi's Sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's Sarcoma. N Engl J Med 335:233-241, 1996
34. Chang Y, Cesarman E, Pessin MS, et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869, 1994.
35. Piedbois P, Frikha H, Martin L, et al: Radiotherapy in the management of epidemic Kaposi's Sarcoma. Int J Radiat Oncol Biol Phys 30.1207-1211, 1994.
36. Le BJ, Frikha H, Piedbois P, et al: Radiotherapy in the management of epidemic Kaposi's Sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 30:263-266, 1994.
37. Cooper JS, Fried PR: Toxicity of oral radiotherapy in patients with acquired immunodeficiency syndrome. Arch Otolaryngol Head Neck Surg 113:327-328, 1987.
38. Holland JM, Swift PS: Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 193:251-254, 1994.
39. Piccinno R, Caccialanza M, Cusini M: Role of radiotherapy in the treatment of epidemic Kaposi's Sarcoma: Experience with sixty-five cases. J Am Acad Dermatol 32:1000-1003, 1995.
40. Berson AM, Quivey JM, Harris JW, et al: Radiation therapy for AIDS-related Kaposi's Sarcoma. Int J Radiat Oncol Biol Phys 19:569-575, 1990.
41. Cooper JS, Fried PR: Defining the role of radiation therapy in the management of epidemic Kaposi's Sarcoma. Int J Radiat Oncol Biol Phys 13:35-39, 1987.
42. de Wit R, Danner SA, Bakker PJ, et al: Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's Sarcoma. J Intern Med 229:35-40, 1991.
43. Ghabrial R, Quivey JM, Dunn JJ, et al: Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's Sarcoma of the eyelids and conjunctiva. Arch Ophthalmol 110:1423-1426, 1992.
44. Stelzer KJ, Griffin TW: A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's Sarcoma. Int J Radiat Oncol Biol Phys 27:1057-1061, 1993.
45. Brunt AM, Phillips RH: Strontium-90 for conjunctival AIDS-related Kaposi's sarcoma: the first case report. Clin Oncol (R Coll Radiol) 2:118-119, 1990.
46. Vapnek JM, Quivey JM, Carroll PR: Acquired immunodeficiency syndrome-related Kaposi's sarcoma of the male genitalia: Management with radiation therapy. J Urol 146:333-336, 1991.
47. Nemechek PM, Corder MC: Radiation recall associated with vinblastine in a patient treated for Kaposi Sarcoma related to acquired immune deficiency syndrome. Cancer 70:1605-1606, 1992.
48. Stelzer KJ, Griffin TW, Koh WJ: Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome Cancer 71:1322-1325, 1993.
49. Silverman SJ: Oral cancer education and HIV-associated malignancies. J Cancer Education 9-152-154, 1994.
50. Macklis RM: Atypical radiation toxicity in patients with classical Kaposi's Sarcoma. Tumori 77:491-495, 1991.
51. Miller RF, Tomlinson MC, Cottrill CP, et al: Bronchopulmonary Kaposi's Sarcoma in patients with AIDS. Thorax 47:721-725, 1992.
52. Xu Y, Conway B, Montaner JS, et al. Effect of low-dose gamma radiation of HIV replication in human peripheral blood mononuclear cells. Photochem Photobiol 64:238-241, 1996.
53. Costleigh BJ, Miyamoto CT, Micaily B, et al: Heightened sensitivity of the esophagus to radiation in a patient with AIDS. Am J Gastroenterol 90:812-814, 1995.
54. Rabkin CS, Biggar RJ, Baptiste MS, et al: Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int J Cancer 55:208-212, 1993.
55. Gail MH, Pluda JM, Rabkin CS, et al: Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 83:695-701, 1991.
56. Rabkin CS, Hilgartner MW, Hedberg KW, et al: Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 267:1090-1094, 1992.
57. Kaplan LD: HIV-associated lymphoma AIDS Clin Rev 94:145-166, 1993.
58. Herndier BG, Kaplan LD, McGrath MS Pathogenesis of AIDS lymphomas. AIDS 8:1025-1049, 1994.
59. Levine AM: AIDS-associated malignant lymphoma. Med Clin North Am 76: 253-268, 1992.
60. Kaplan LD, Shiramizu B, Herndier B, et al: Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: Identification of a subgroup with favorable clinical outcome. Blood 85:1727-1735, 1995.
61. Kaplan L, Straus D, Testa M et al: Randomized trial of standard dose m-BACOD with GM-CSF vs reduced dose m-BACOD for systemic related lymphoma (abstract). Proc Am Assoc Clin Oncol 14:818, 1995.
62. Kaplan LD, Abrams DI, Feigal E, et al: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719-724, 1989.
63. Freeman CR, Shustik C, Brisson ML, et al: Primary malignant lymphoma of the central nervous system. Cancer 58-1106-1111, 1986.
64. Ling SM, Roach Mr, Larson DA, et al: Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus: Ten years of treatment experience at the University of California San Francisco. Cancer 73:2570-2582, 1994.
65. Shiramizu B, McGrath MS: Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 5:323-330, 1991.
66. Baumgartner JE, Rachlin JR, Beckstead JH, et al: Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73:206-211, 1990.
67. Forsyth PA, Yahalom J, DeAngelis LM: Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 44:1473-1479, 1994.
68. From the Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269.729-730, 1993.
69. Rabkin CS, Yellin F: Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 86:1711-1716, 1994.
70. From the Centers for Disease Control. Risk for cervical disease in HIV-infected women - New York City. JAMA 265.23-24, 1991.
71. Williams AB, Darragh TM, Vranizan K, et al: Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 83:205-211, 1994.
72. Tweddel G, Heller P, Cunnane M, et al: The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol 52:161-164, 1994.
73. Mandelblatt JS, Fahs M, Garibaldi K, et al: Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS 6:173-178, 1992.
74. Maiman M, Fruchter RG, Guy L, et al: Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 71:402-406, 1993.
75. Mueller BU, Pizzo PA: Cancer in children with primary or secondary immunodeficiencies. J Pediat 126:1-10, 1995.
76. Spanos WJ, Clery M, Perez CA, et al: Late effect of multiple daily fraction palliation schedule for advanced pelvic malignancies (RTOG 8502). Int J Radiat Oncol Biol Phys 29:961-967, 1994.
77. Melbye M, Rabkin C, Frisch M, et al: Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 139.772-780, 1994.
78. Northfelt DW, Swift PS, Palefsky JM: Anal dysplasia: Pathogenesis, diagnosis and management, in Krown SE, von Roenn JH, (eds): Hematologic and Oncologic Aspects of HIV Infection, pp 1177-1188. Hematology Oncology Clinics of North America. Philadelphia, WB Saunders, 1996.
79. Flam MS, John MJ, Peters T et al: Radia- tion and 5-fluorouracil vs. radiation, 5FU, mitomycin-C in the treatment of anal canal carcinoma: Preliminary results of a phase III randomized RTOG/ECOG intergroup trial. Proc Am Soc Clin Oncol 12:192, 1993.
80. Biggar RJ, Curtis RE, Cote TR, et al: Risk of other cancers following Kaposi's sarcoma relation to acquired immunodeficiency syndrome. Am J Epidemiol 139:362-368, 1994.
81. Hessol NA, Katz MH, Liu JY, et al: Increased incidence of Hodgkin disease in homosexual men with HIV infection Ann Intern Med 117:309-311, 1992.
82. Medeiros LJ, Greiner TC: Hodgkin's disease. Cancer 357-369, 1995.
83. Hammer SM, Katzenstein DA, Highes MD, et al: A trila comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 counts from 200 to 500 per cubic millimeter. N Engl J Med 335:1081-1090, 1996.